NRG Oncology Biospecimen Bank awarded NCI funding, ‘Exceptional’ score
The NRG Oncology Biospecimen Bank (NRG-BB) will be awarded six more years of funding from the National Cancer Institute (NCI) to provide biospecimen banking support for the NCI National Clinical Trials Network (NCTN) group NRG Oncology. During the peer review grant renewal process, the NRG-BB was ranked within the “Exceptional” range with a score of…